Submitted by Anonymous (not verified) on 16 February 2026 - 11:00
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 14, Status: Authorised